Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
SillaJen, Inc.
*MAILING ADDRESS
9th Floor, 109, Sogong-ro, Jung-gu
*CITY
Seoul
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Korea, South
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
04525
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Korea, South
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer.
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number: 97695576
Filing Date: 11/29/2022
To the Commissioner for Trademarks:
MARK: PEXIOVEQ (Standard Characters, see mark) The literal element of the mark consists of PEXIOVEQ. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant,
SillaJen, Inc.,
a corporation of Korea, South,
having an address of
9th Floor, 109, Sogong-ro, Jung-gu Seoul 04525 Korea, South XXXX
requests
registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:
International Class
005:
Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer. Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class
042:
Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer. Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information:
Alicia Morris Groos.
Other appointed attorneys are all other attorneys with the firm. Alicia Morris Groos of Pirkey Barber PLLC,
is a member of the XX bar,
admitted to the bar in XXXX,
bar membership no. XXX,
and the attorney(s)
is located at 1801 East 6th Street, Suite 300 Austin, Texas 78702 United States 512-322-5200(phone) tmcentral@pirkeybarber.com The docket/reference number is KIRN009US1. Alicia Morris Groos submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant
owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark
correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature:
/JaeGyeong Kim/ Date:
11/23/2022
Signatory's Name:
JaeGyeong Kim
Signatory's Position:
CEO
Signatory's Phone Number: Not Provided
Signature method:
Sent to third party for signature
Payment Sale Number: 97695576 Payment Accounting Date: 11/29/2022
Serial Number: 97695576 Internet Transmission Date: Tue Nov 29 11:50:38 ET 2022 TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202211291150397 07550-97695576-820499fa3c01868f3f1963d31 ab221030b4ee81c9713a71e50de887a46afcbfc5 -CC-50381196-20221020170422475296